Stockscreener 앱 받기
10.85
2.16%
-0.24
시간 외 거래:
10.79
-0.06
-0.55%
Delcath Systems Inc 주식(DCTH)의 최신 뉴스
Delcath Systems announces inducement grants - Medical Buyer
How (DCTH) Movements Inform Risk Allocation Models - Stock Traders Daily
Implied volatility surging for Delcath Systems stock options - MSN
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Daily Tribune News
Delcath Systems announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
New Delcath hires receive 24,500 stock units over 3 years - Stock Titan
Dental EconomicsDelcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - FinancialContent
Delcath Systems, Inc.Common Stock (NQ: DCTH - FinancialContent
Delcath Systems (DCTH) director receives grant of 22,500 stock options at $11.61 - Stock Titan
Delcath Systems (NASDAQ: DCTH) director receives 22,500 stock options at $11.61 strike - Stock Titan
Delcath Systems (DCTH) director awarded 22,500 stock options at $11.61 - Stock Titan
Director at Delcath (NASDAQ: DCTH) awarded 22,500 stock options - Stock Titan
Delcath (DCTH) awards director 22,500 options at $11.61 strike - Stock Titan
Delcath Systems, Inc. 8-K Filing May 13, 2026 – Company Information, Equity Incentive Plan, and SEC Compliance 212 - Minichart
Delcath Shareholders Approve Expanded Equity Plan and Governance - TipRanks
Delcath Systems shareholders approve equity plan amendment and board elections By Investing.com - Investing.com South Africa
Delcath Systems shareholders approve equity plan amendment and board elections - Investing.com
Delcath (NASDAQ: DCTH) approves 1.8M-share boost to 2020 equity plan - Stock Titan
Earnings call transcript: Delcath Systems Q1 2026 beats EPS forecast, stock rises - Investing.com Canada
Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference - Yahoo Finance
TradingKey - TradingKey
Delcath Systems Q1 2026: -$0.03 EPS Tops Estimates — Deep Dive - AlphaStreet
Tangible book value per share of Delcath Systems, Inc. – SWB:DV3R - TradingView
Delcath Systems Balances Growth with Rising Costs - The Globe and Mail
MSN Money - MSN
H.C. Wainwright Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Delcath Systems, Inc. (NASDAQ:DCTH) Q1 2026 Earnings Call Transcript - Insider Monkey
Delcath Systems (NASDAQ:DCTH) Announces Quarterly Earnings Results - MarketBeat
Q1 2026 Delcath Systems Inc Earnings Call Transcript - GuruFocus
Delcath Systems, Inc. (DCTH) Stock Analysis: Aiming for an 89.80% Upside in the Medical Device Sector - DirectorsTalk Interviews
Uveal Melanoma Treatment Market is expected to Hit US$ 2.7 - openPR.com
Delcath Systems Reports First Quarter 2026 Results and Business Highlights - BioSpace
Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026 - BioSpace
Number of shareholders of Delcath Systems, Inc. – DUS:DV3R - TradingView
Delcath Systems, Inc. (DCTH) reports Q1 loss, misses revenue estimates - MSN
Delcath Systems Q1 Earnings Call Highlights - MarketBeat
Delcath Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Delcath Systems, Inc. (DCTH) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
DCTH: Q1 saw record patient starts, 36% volume growth, and strong 2026 revenue guidance - TradingView
Delcath presents data on liver cancer treatment in breast cancer patients By Investing.com - Investing.com South Africa
Delcath presents data on liver cancer treatment in breast cancer patients - Investing.com UK
Delcath Systems Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Delcath Systems (NASDAQ:DCTH) Surpasses Q1 Estimates, Guidance Points to Continued Growth - ChartMill
Delcath Systems | 10-Q: Q1 2026 Earnings Report - Moomoo
Delcath Systems (NASDAQ: DCTH) grows Q1 2026 sales but posts small loss - Stock Titan
DELCATH SYSTEMS ($DCTH) Releases Q1 2026 Earnings - Quiver Quantitative
Delcath (NASDAQ: DCTH) Q1 revenue hits $25M with 2026 outlook of $100M+ - Stock Titan
Delcath Systems Sees Positive Adjusted EBITDA for 2026 >DCTH - Moomoo
Cancer treatment company targets $100M sales with 29 centers active - Stock Titan
A liver-targeted breast cancer procedure drew new data at ESMO - Stock Titan
1.10%
0.28%
자본화:
|
볼륨(24시간):